A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females - Trial NCT06380205
Access comprehensive clinical trial information for NCT06380205 through Pure Global AI's free database. This Phase 1 trial is sponsored by Incyte Corporation and is currently Recruiting. The study focuses on Healthy Participants. Target enrollment is 24 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Incyte Corporation
Timeline & Enrollment
Phase 1
May 07, 2024
Jun 07, 2024
Primary Outcome
Levonorgestrel (LNG) concentration in plasma,Ethinyl estradiol (EE) concentration in plasma
Summary
The purpose of this study is to evaluate the drug interaction between povorcitinib and the
 oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06380205
Non-Device Trial

